SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008597
Filing Date
2023-05-09
Accepted
2023-05-08 18:19:26
Documents
80
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q btai-20230331x10q.htm   iXBRL 10-Q 1800398
2 EX-10.1 btai-20230331xex10d1.htm EX-10.1 135085
3 EX-10.2 btai-20230331xex10d2.htm EX-10.2 61624
4 EX-10.3 btai-20230331xex10d3.htm EX-10.3 49285
5 EX-31.1 btai-20230331xex31d1.htm EX-31.1 17372
6 EX-31.2 btai-20230331xex31d2.htm EX-31.2 17591
7 EX-32.1 btai-20230331xex32d1.htm EX-32.1 10352
8 EX-32.2 btai-20230331xex32d2.htm EX-32.2 8785
9 GRAPHIC btai-20230331x10q006.jpg GRAPHIC 81524
10 GRAPHIC btai-20230331x10q007.jpg GRAPHIC 47678
  Complete submission text file 0001558370-23-008597.txt   7647315

Data Files

Seq Description Document Type Size
11 EX-101.SCH btai-20230331.xsd EX-101.SCH 45840
12 EX-101.CAL btai-20230331_cal.xml EX-101.CAL 45661
13 EX-101.DEF btai-20230331_def.xml EX-101.DEF 187600
14 EX-101.LAB btai-20230331_lab.xml EX-101.LAB 450547
15 EX-101.PRE btai-20230331_pre.xml EX-101.PRE 344248
74 EXTRACTED XBRL INSTANCE DOCUMENT btai-20230331x10q_htm.xml XML 1071452
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38410 | Film No.: 23899316
SIC: 2834 Pharmaceutical Preparations